Stansky Michael P

Director Stansky buys 610,000 shares at $2.50 for $1,525,000 at TLSI; stock down -61.9% from 52-week high, 2 prior buys at this ticker showed 0% 90-day win rate.

Director Michael P Stansky purchased 610,000 shares across 2 separate transactions on 2026-05-15 at $2.50 per share for a total of $1,525,000.00, increasing his post-transaction holdings to 399,698 shares. The purchase price of $2.50 sits well below the current price of $3.03 and dramatically below the 52-week high of $7.95, with the stock currently -61.9% from its peak and down -34.8% over 30 days. Critically, Stansky's same-ticker history at TLSI shows 2 prior buys on 2026-02-23, both yielding -34.6% average 90-day returns with a 0% win rate at the 90-day mark—a pattern of unsuccessful timing on this specific stock that provides context for evaluating this latest accumulation despite the company's recent positive fundamentals (53.4% annual revenue growth, $1.5M net income latest quarter).

Director Stansky buys 361,098 shares for $1.5M at $4.10 amid cluster buy; TLSI unprofitable but +59% revenue growth.

Director Michael P. Stansky purchased 361,098 shares across 2 separate transactions totaling $1,480,501.80 at $4.10 per share on 2026-02-23. This transaction occurs within a cluster pattern where 4 other insiders also bought within the past 14 days, suggesting coordinated insider accumulation despite the company's challenging profitability position. TriSalus is unprofitable with net income of $-10,811,000.00 over its most recent full fiscal year, yet the company generated $11,566,000.00 in latest-quarter revenue with +59.0% annual revenue growth, indicating aggressive commercial traction in a pre-profitability stage. The stock trades at $4.99 (current), down 33.5% from its 52-week high of $7.50 and down 20.7% over 90 days, placing the insider purchases at a lower valuation than historical recent levels.